companydata.dkcompanydata.dk

FDA Invest ApS: Financial statements 2024

CVR: 43586408

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

FDA Invest ApS (CVR 43586408) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 3,585. Equity in the 2024 report amounted to DKK 36,508. The solvency ratio was 100%.

Profit/Loss
DKK 3,585
Equity
DKK 36,508
Total Assets
DKK 36,508
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

FDA Invest ApS publishes interim reportMay 28, 2024

FDA Invest ApS has published its interim report for the period October 18, 2022 to December 31, 2023.

About FDA Invest ApS

FDA Invest ApS was a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2022. The company has been dissolved on 5 May 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 3,585. Equity in the 2024 report amounted to DKK 36,508.

Source: annual report 2024, Danish Business Authority